Dr Reddys Laboratories Ltd Share Price Today - Live Blog for April 30, 2026

Dr Reddys Laboratories Ltd's share price has fallen by -0.58%, a situation worth noting. At present, the stock is trading at 1322.10. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 20.1000, while the industry PE ratio is 33.4163.

Dr Reddys Laboratories Ltd witnessed a -0.53% drop in its share price and is currently trading at 1322.70. With the stock's PE at 20.1000 and the industry PE at 33.4163, investors are weighing their options.

Dr Reddys Laboratories Ltd share price has declined by -0.53%, and it's currently trading at 1322.70. The stock maintains a PE of 20.1000, while the industry PE is 33.4163, prompting discussions about its valuation.

The stock of Dr Reddys Laboratories Ltd is facing a -0.27% decline and is currently trading at 1326.20 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.27%, signalling a challenging period. Currently trading at 1326.20, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd shares saw a -0.44% decrease, reaching a current market price of 1324.00. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 20.1000, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price has fallen by -0.44%, presenting both challenges and opportunities for investors. As of now, it's trading at 1324.00, and market participants are assessing the implications. The stock has a PE ratio of 20.1000, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price has dropped by -0.91%, a development that warrants careful analysis. Presently trading at 1317.70, investors are assessing whether this presents an opportunity or a risk.

With a -0.91% decrease, Dr Reddys Laboratories Ltd's share price is now at 1317.70. The stock is currently trading at a PE of 20.1000, while the industry PE is 33.4163, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd experienced a -0.51% dip in its share price and is currently trading at 1323.00. The stock has a PE ratio of 20.1000, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

After a -0.51% decline, Dr Reddys Laboratories Ltd shares are now trading at 1323.00. The stock has a PE ratio of 20.1000, an ROE of 16.0277 and a debt to equity ratio of 0.1625.